Immunic, Inc. (IMUX)
6.97
-0.13
(-1.83%)
USD |
NASDAQ |
Oct 16, 16:00
6.955
-0.02
(-0.22%)
After-Hours: 20:00
Immunic Cash from Investing (Quarterly) : -0.249M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.249M |
| March 31, 2026 | -0.002M |
| December 31, 2025 | -0.011M |
| September 30, 2025 | -0.067M |
| June 30, 2025 | -0.036M |
| March 31, 2025 | -0.047M |
| December 31, 2024 | -0.003M |
| September 30, 2024 | -0.05M |
| June 30, 2024 | -0.18M |
| March 31, 2024 | -0.031M |
| December 31, 2023 | -0.165M |
| September 30, 2023 | -0.044M |
| June 30, 2023 | 4.336M |
| March 31, 2023 | 5.335M |
| December 31, 2022 | -9.628M |
| September 30, 2022 | -0.073M |
| June 30, 2022 | -0.028M |
| March 31, 2022 | -0.012M |
| December 31, 2021 | -0.019M |
| September 30, 2021 | -0.02M |
| June 30, 2021 | -0.018M |
| March 31, 2021 | -0.01M |
| December 31, 2020 | -0.024M |
| September 30, 2020 | -0.063M |
| June 30, 2020 | -0.055M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.004M |
| December 31, 2019 | -0.025M |
| September 30, 2019 | 1.237M |
| June 30, 2019 | 9.331M |
| March 31, 2019 | -0.007M |
| December 31, 2018 | -0.02M |
| September 30, 2018 | -0.005M |
| June 30, 2018 | 0.143M |
| March 31, 2018 | -0.15M |
| December 31, 2017 | -0.111M |
| September 30, 2017 | -0.169M |
| June 30, 2017 | -0.127M |
| March 31, 2017 | -0.271M |
| December 31, 2016 | -0.119M |
| September 30, 2016 | -0.272M |
| June 30, 2016 | -0.04M |
| March 31, 2016 | -0.123M |
| December 31, 2015 | 0.488M |
| September 30, 2015 | 0.036M |
| June 30, 2015 | -1.19M |
| March 31, 2015 | -0.615M |
| December 31, 2014 | -0.183M |
| September 30, 2014 | -0.541M |
| June 30, 2014 | -0.463M |
| March 31, 2014 | -0.853M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | -8.529M |
| Sionna Therapeutics, Inc. | 21.47M |
| Alnylam Pharmaceuticals, Inc. | -363.46M |
| Anika Therapeutics, Inc. | -1.28M |
| Savara, Inc. | 32.60M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -31.00M |
| Cash from Financing (Quarterly) | 0.118M |
| Free Cash Flow | -88.05M |
| Free Cash Flow Per Share (Quarterly) | -0.735 |
| Free Cash Flow to Equity (Quarterly) | -31.39M |
| Free Cash Flow to Firm (Quarterly) | -31.25M |
| Free Cash Flow Yield | -48.55% |